Alvarez & Marsal Taxand Managing Director, Al Liguori, was quoted in the Bloomberg.com article “AbbVie Moves Allergan Profits to U.S. in Partial GOP Tax Law Win.”
"The 2017 tax overhaul cut the rate from 35% to 21% and killed off nearly all remaining reasons for companies to invert. But Allergan will likely have to pay a new tax in the law on what is known as global intangible low-taxed income, or GILTI, said Albert W. Liguori, managing director at consulting firm Alvarez & Marsal Taxand."
Click here to read the full article.
This article was originally published on Bloomberg.com on June 26th. ©2019 Bloomberg L.P.
Managing Director Kevin M. Jacobs Featured in The Wall Street Journal
September 11, 2025
A&M Tax Managing Director Kevin M. Jacobs was recently featured in The Wall Street Journal in an article highlighting the cash savings companies are benefiting from under the new tax law.
Changes Coming to the Washington Sales Tax Landscape on October 1, 2025
September 11, 2025
In May 2025, Washington enacted multiple tax bills into law, including Senate Bill 5814 (SB 5814), which takes effect on October 1st and will broaden the sales and use tax base and the Business and Occupation (B&O) tax retailing classification to include several new services.
US-Mexico treaty notification and protective claim requirements
September 8, 2025
Companies in Mexico with a local presence that are currently undergoing, or may in the future undergo, a tax review for FY 2020 of its transfer pricing policies involving the United States, need to file a protective claim/notification no later than September 30th, 2025.
Alvarez & Marsal Tax Expands into Thailand with Strategic Senior Hires
September 2, 2025
Firm expansion capitalizes on region’s remarkable growth and demand for sophisticated tax solutions.
